StockData
InflaRx N.V. logo

InflaRx N.V. (IFRX) stock

IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 5/30
$1.15−0.03 (-2.54%)

Close on Nov 17, 2026Market cap $83.14MP/E –Yield –

InflaRx operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -€35.31M. The highest annual figure on record is -€3.31M in fiscal 2015.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€35.31M–
FY2024Dec 31, 2024-€48.56M–
FY2023Dec 31, 2023-€37.81M–
FY2022Dec 31, 2022-€33.74M–
FY2021Dec 31, 2021-€39.94M–
FY2020Dec 31, 2020-€36.53M–
FY2019Dec 31, 2019-€43.20M–
FY2018Dec 31, 2018-€21.55M–
FY2017Dec 31, 2017-€12.15M–
FY2016Dec 31, 2016-€4.99M–
FY2015Dec 31, 2015-€3.31M–

More InflaRx figures

See a number that looks wrong?